FEBRILE ANTIGEN CONTROL SERA— 510(k) K760881

Name: FDA 510(k) clearance K760881
Creator: U.S. Food and Drug Administration
Published: 1976-11-09

Substantially Equivalent

Bd Becton Dickinson Vacutainer Systems Preanalytic

FDA 510(k) clearance K760881 for FEBRILE ANTIGEN CONTROL SERA, Substantially Equivalent on 1976-11-09. Applicant: Bd Becton Dickinson Vacutainer Systems Preanalytic. Device class: 1.

Clearance details

Applicant: Bd Becton Dickinson Vacutainer Systems Preanalytic
Product code: Code GSZ
Device class: Class 1
Regulation: 21 CFR 866.3410
Advisory panel: Microbiology
Date received: 1976-10-21
Decision date: 1976-11-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Washington, DC, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GSZ

view all

K885110 — PROTEUS OX-19 IFA*1989-08-15
K760097 — FEBRILE ANTIGENS & CONTROL SERUMS1976-08-03

More clearances from Bd Becton Dickinson Vacutainer Systems Preanalytic

view all

K003062 — BACTEC MGIT 960 SIR KITS2001-06-06
K003553 — 0.9% SODIUM CHLORIDE INJECTION, USP BD PRE-FILLED FLUSH SYRINGE2001-03-21
K003461 — BD VACUTAINER PASSIVE SHIELDING BLOOD COLLECTION NEEDLE2001-02-01
K002938 — B-D ULTRA-FINE III PEN NEEDLE; MODEL 31G X 3/162000-11-29
K001364 — BD DIRECTIGEN FLU A+B2000-06-28

Data sourced from openFDA. This site is unofficial and independent of the FDA.